Q-omics provides the consensus-scored MIR331 profile across patient tissues and cancer cell-line models. MIR331 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in BRCA. Among the 18 cancer types available for tumor–normal comparison, MIR331 is differentially expressed in 12, with the highest sampling consensus in THCA. Additionally, MIR331 RNA expression shows 19,451 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight BRCA, THCA, and THYM as cancer lineages where MIR331 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR331 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR331 survival associations across molecular data types. MIR331 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR331 RNA expression–survival associations across cancer types. High MIR331 expression shows unfavorable associations in STAD, KIRC and UVM, but favorable associations in BRCA, SKCM and UCS. The BRCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify BRCA as the clearest survival context for MIR331 RNA expression.
This table summarizes MIR331 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR331. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR331 shows lower tumor expression in THCA and KICH and higher tumor expression in LIHC, CHOL, STAD and PAAD. The THCA box plot shows higher MIR331 RNA expression in normal versus tumor tissue (log2 FC = −1.078, t-test p < 0.001).
This table shows molecular features associated with MIR331 in patient tissues and cancer cell lines. In patient samples, MIR331 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
